NCT07453355Completed
EXPRESSIVE ARTS THERAPY FOR HOPE IN PEOPLE WITH SCHIZOPHRENIA
The Role of Expressive Arts Therapy in Strengthening Hope in Individuals With Schizophrenia: A Randomized Controlled Trial (EAT-HOPE)
Source: ClinicalTrials.gov · Last updated 10 Mar 2026
Brief summary (registry, in English)
This randomized controlled trial aimed to evaluate the effectiveness of an expressive arts therapy programme based on positive psychotherapy principles in strengthening hope among individuals diagnosed with schizophrenia. Hope is a central component of recovery in schizophrenia, yet structured nursing interventions specifically targeting hope remain limited. The study was conducted with 50 inpatients diagnosed with schizophrenia at a mental health hospital in Türkiye. Participants were randomly assigned to either an intervention group or a control group. The intervention group participated in an eight-session expressive arts therapy programme delivered in small groups, while the control group received standard psychiatric care. Hope levels were assessed before and after the intervention using the Herth Hope Scale. The findings demonstrated that participants who received expressive arts therapy showed significant improvements in overall hope and its key dimensions, including future orientation, positive readiness and expectancy, and connectedness, compared with those receiving standard care. This study suggests that expressive arts therapy may be an effective recovery-oriented nursing intervention to strengthen hope and support psychological recovery in individuals with schizophrenia.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 1 Mar 2026
- Start date
- 22 Jul 2025
- Primary completion date
- 30 Oct 2025
- Lead sponsor
- Ondokuz Mayıs University
- Diseases
- Schizophrenia
- NCT number
- NCT07453355
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 22 Jul 2025 to the primary completion date, 30 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment
- Severe physical illness preventing participation
Other
- Acute psychotic symptoms requiring intensive treatment
- Refusal to participate or withdrawal of consent
Who the study is looking for
- Diagnosis of schizophrenia according to clinical evaluation
- Age between 18 and 65 years
- Hospitalized in a psychiatric inpatient unit
- At least six months since diagnosis
- Ability to read and understand assessment tools
- Clinically stable without acute psychotic symptoms
- Provided written informed consent
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| samsun Mental Health Hospital Coordinator of this site? Confirm its status | Atakent | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.